Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen R Karpen

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2020
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting reportRoslyn B Mannon, Randall E Morris, Michael Abecassis, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2023
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter N Taylor, Kimberly S Collins, Anna Lam, et al.
Frontiers in Immunology|October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trialCassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|February 25, 2020
Use of biomarkers to improve immunosuppressive drug development and outcomes in renal organ transplantation: A meeting reportRoslyn B Mannon, Randall E Morris, Michael Abecassis, et al.
The Lancet. Diabetes & Endocrinology|November 6, 2023
C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysisPeter N Taylor, Kimberly S Collins, Anna Lam, et al.
Frontiers in Immunology|October 16, 2024
TNF-α inhibitors for type 1 diabetes: exploring the path to a pivotal clinical trialCassandra Bazile, Magdy M Abdel Malik, Courtney Ackeifi, et al.
Pageof 2